Biotech Values

[DewDiligence]

NEO can be delivered in 6-8 weeks, according to ADXS, and the manufacturing output has the stability and volume to suffice for two years of monthly retreatments.

The NEO IND was cleared by the FDA in Mar 2017 (#msg-129238272), and AMGN will be starting phase-1 imminently (if they have not already done so).

No shortage of competition in this race.

All told, I like AMGN's chances, and one doesn't have to pay much to participate. ADXS' EV has dropped to <$200M during the sell-off this week.